UCLA Molecular and Medical Pharmacology  









Faculty

Department / Division Affiliations
Professor, Anesthesiology, Molecular & Medical Pharmacology
Member, ACCESS Program: Dept. of Molecular & Medical Pharmacology, Neuroscience Graduate Program, Brain Research Institute
ACCESS Affinity Group:
ACCESS Affinity - Molecular & Medical Pharmacology
Research Interest:
A. 1. Structural basis of receptor pharmacological heterogeneity: different subtypes of receptors differing in various pharmacological properties are produced from structural isoforms of the heteropentameric protein containing different subunit composition. We study this with protein chemistry, immunochemistry, cell culture, and electrophysiology of cloned recombinant receptors expressed in heterologous cells such as frog oocytes and insect cell lines driven by Baculovirus promoters. Such studies can tell us about the mechanism of action of drugs active on the brain via the GABA system, including sedatives, anesthetics, antiepileptics, and anti-anxiety agents, and help to develop better new medications.

2. Functional domains in the GABAA receptor protein: we identified amino acid residues in the protein that are involved in ligand binding using affinity labeling with radio-ligands and microsequencing, and developed a new model of the agonist and modulatory drug sites of interaction in the protein that could convert binding energy into conformational changes regulating ion channel gating. We study this with site-directed mutagenesis and expression of mutant receptors as above.

B. An animal model of drug dependence and epileptogenesis: we gave rats chronic intermittent administration of ethanol to produce multiple withdrawals, resulting in persistent severe withdrawal signs, assessed as an increased seizure susceptibility, using the GABA blocking convulsant, pentylenetetrazol. The animals resemble those made pre-epileptic, or `kindled', by chronic stimulation with subconvulsant levels of electrical activation or convulsant drugs. This seems to be a useful model of human addictive behavior as well as an interesting example of brain plasticity in response to environmental stressors. We are searching for a molecular explanation of the behavioral alterations involving GABAA receptors; we found hypofunction of GABA-mediated inhibition in hippocampus.

C. An animal model of mental retardation and possibly epilepsy: we obtained a mouse mutant deleted in chromosome 7, synthenic with human chromosome 15, an area involved in the human mental retardation mutation, Angelman's Syndrome (AS). We showed that the mouse lacks 3 GABA receptor subunits and that this changes receptor binding characteristics. We are comparing phenotypic characteristics to genotypic in these animals, which are neurologically abnormal, runted and die young. We are also culturing cells from embryonic brains of the mutants to study whether any cellular properties, including GABA responses, are impaired. At the same time, we are looking at human cases of AS and determining whether all patients have epilepsy and are lacking on or more GABA receptor genes.

 

Richard Olsen, Ph.D.

Email Address:
rolsen@mednet.ucla.edu

Address:
Office
CHS
Los Angeles, CA 90095
UNITED STATES

Laboratory
CHS
Los Angeles, CA 90095
UNITED STATES

Phone Number:
310-825-5093
310-825-5748


Login to the Faculty Database


Publications:
Li G-D, Chiara DC, Sawyer GW, Husain SS, Olsen RW, and Cohen JB GABA-A receptor anesthetic binding sites identified at subunit interfaces by photolabeling. . J Neurosci 2006; 26: 11599-11605..
Leil TA, Chen Z, Chang CSS, Olsen RW Gamma-aminobutyric acid receptor-associated protein traffics GABA-A receptors to the plasma membrane in neurons. J Neurosci 2004; 24: 11429-11438.
Hanchar, HJ Dodson, PD Olsen, RW Otis, TS Wallner, M Alcohol-induced motor impairment caused by increased extrasynaptic GABA(A) receptor activity.. Nature neuroscience. . 2005; 8(3): 339-45.